Peter K. Daley

300 Prince Philip Drive
St. John's, NL A1B3V6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Journal: The New England journal of medicine

Published: June 17, 2026

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Journal: The New England journal of medicine

Published: April 22, 2026

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

Journal: JAMA network open

Published: February 27, 2026

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial.

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 11, 2025

Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE.

Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE.

Journal: BMJ open

Published: December 08, 2025

A qualitative scan on the challenges of AMR in Canada and experts' proposed solutions.

A qualitative scan on the challenges of AMR in Canada and experts' proposed solutions.

Journal: Canadian journal of microbiology

Published: November 19, 2025

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial.

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial.

Journal: Trials

Published: November 06, 2025

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Journal: Contemporary clinical trials

Published: September 16, 2025

National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concern.

National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concern.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: August 27, 2025

Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings.

Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings.

Journal: BMJ open

Published: August 03, 2025

Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study.

Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study.

Journal: Canadian journal of public health = Revue canadienne de sante publique

Published: June 25, 2025

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia.

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia.

Journal: Critical care explorations

Published: May 30, 2025

Showing 1-12 of 50

Last Updated: 09/26/2026